USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 13, 2021 (est) | Sep 30, 2021 | - | $-0.25 | $-0.24 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 13, 2021 (est) | Sep 30, 2021 | - | $0.00 | $0.00 |
Adial Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Nov 13, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.21 | $-0.22 | $-0.21 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.97 | $-0.97 | $-0.97 |
| Dec 2022 | 2 | $-0.76 | $-0.83 | $-0.70 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.21 | $-0.18 | $-0.14 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.97 | $-0.87 | $-0.77 |
| Dec 2022 | 0 / 0 | $-0.76 | $-0.68 | $-0.54 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 12, 2021 | Jun 2021 | $-0.21 | $-0.25 | -21.95% |
| May 17, 2021 | Mar 2021 | - | $-0.30 | - |
| Mar 22, 2021 | Dec 2020 | $-0.25 | $-0.25 | - |
| Nov 13, 2020 | Sep 2020 | $-0.18 | $-0.24 | -33.33% |
| Aug 13, 2020 | Jun 2020 | $-0.18 | $-0.16 | 11.11% |
| May 14, 2020 | Mar 2020 | - | $-0.22 | - |
| Mar 20, 2020 | Dec 2019 | $-0.19 | $-0.19 | - |
| Nov 14, 2019 | Sep 2019 | $-0.29 | $-0.17 | 41.38% |
| Aug 13, 2019 | Jun 2019 | $-0.23 | $-0.21 | 8.70% |
| May 13, 2019 | Mar 2019 | $-0.17 | $-0.33 | -94.12% |
| Feb 19, 2019 | Dec 2018 | $-0.18 | $-0.19 | -5.56% |
| Nov 14, 2018 | Sep 2018 | $-0.26 | $-1.48 | -469.23% |
| Jul 30, 2018 | Jun 2018 | - | $-0.27 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2021 | Dec 2020 | $-0.89 | $-0.87 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $-0.90 | - |
| Feb 19, 2019 | Dec 2018 | $-2.54 | $-1.94 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 17, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 22, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 13, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 13, 2020 | Jun 2020 | - | $0.00 | - |
| May 14, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 14, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 13, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 13, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Feb 19, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 14, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Jul 30, 2018 | Jun 2018 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Feb 19, 2019 | Dec 2018 | $0.00 | $0.00 | - |
ADIL's next estimated earnings date (based on same quarter last year's report date) is Nov 13, 2021 for the fiscal quarter ending Sep 30, 2021.
Adial Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
ADIL's earnings per share (EPS) was $-0.25, missing the consensus analysts forecast of $-0.21 by -21.95%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -16.67%, and lower than the same period a year before (Jun 2020) by 56.25%.
Revenues were $0.00.
The company reported a net income of $-4.44M.Free cash flow for the quarter was $-3.24M , compared to $-2.87M last quarter and $-985.17K a year before.
ADIL ended the quarter with $273.29K in total debt, a decrease of -12.69% compared to the previous quarter.
Adial Pharmaceuticals's previous annual earnings date was Mar 22, 2021 for its fiscal year ended Dec 31, 2020.
ADIL's earnings per share (EPS) was $-0.87, beating the consensus analysts forecast of $-0.89 by -2.25% , and higher than the previous year's EPS (Dec 2019) by -3.33%.
Revenues were $0.00.
The company reported a net income of $-10.89M.
Adial Pharmaceuticals reported a free cash flow of $-7.63M for its fiscal year, compared to $-6.34M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.